VibraXX
Live Quiz Arena
🎁 1 Free Round Daily
⚡ Enter Arena
HomeCategoriesHuman Body & HealthQuestion
Question
Human Body & Health

A novel mRNA vaccine elicits a weak initial antibody response; which adaptation is most likely to enhance long-term protection through increased antibody affinity maturation in germinal centers?

A)Reducing the mRNA lipid nanoparticle size
B)Lowering the vaccine dose administered
C)Including a TLR agonist adjuvant
D)Using a non-degradable mRNA sequence

💡 Explanation

Including a TLR agonist adjuvant enhances T follicular helper cell activation, which promotes B cell affinity maturation in germinal centers because this boosts the selection of B cells with higher affinity antibodies. Therefore, long-term protection is improved rather than merely changing mRNA properties or dosage.

🏆 Up to £1,000 monthly prize pool

Ready for the live challenge? Join the next global round now.
*Terms apply. Skill-based competition.

⚡ Enter Arena

Related Questions

Browse Human Body & Health